Kiora Pharmaceuticals (KPRX)
2.56
-0.02 (0.78%)
Upcoming Events
Latest Headlines
Form 4 KIORA PHARMACEUTICALS For: Sep 17 Filed by: Lane Keith J.
September 17, 2026 9:35 PM - SEC Filing
Form 3 KIORA PHARMACEUTICALS For: Sep 08 Filed by: Lane Keith J.
September 17, 2026 9:28 PM - SEC Filing
Form SCHEDULE 13G KIORA PHARMACEUTICALS Filed by: Baselake Partners, LP
September 17, 2026 4:07 PM - SEC Filing
Kiora Pharmaceuticals names new clinical development chief
September 8, 2026 7:02 AM - StreetInsider
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs
September 8, 2026 7:02 AM - StreetInsider
Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation
August 19, 2026 7:02 AM - StreetInsider
Form 8-K KIORA PHARMACEUTICALS For: Aug 19
August 19, 2026 7:01 AM - SEC Filing
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: ADAR1 Capital Management, LLC
August 14, 2026 5:04 PM - SEC Filing
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC
August 14, 2026 4:49 PM - SEC Filing
Form SCHEDULE 13G KIORA PHARMACEUTICALS Filed by: PERCEPTIVE ADVISORS LLC
August 10, 2026 11:59 AM - SEC Filing
Kiora Pharmaceuticals (KPRX) Tops Q2 EPS by 17c
August 7, 2026 7:34 AM - StreetInsider
Form 8-K KIORA PHARMACEUTICALS For: Aug 07
August 7, 2026 7:03 AM - SEC Filing
Form 10-Q KIORA PHARMACEUTICALS For: Jun 30
August 7, 2026 7:03 AM - SEC Filing
Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 7, 2026 7:03 AM - StreetInsider
Full Article List
